Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Gamma-aminobutyric acid A receptor, alpha 2 or GABRA2 are activated by the major inhibitory neurotransmitter in the mammalian brain and has been found to mediate anxiolytic activity, which plays a key role in emotional and behavioral control.
The Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) pipeline drugs market research report outlays comprehensive information on the Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) targeted therapeutics development with respective active and dormant or discontinued projects.
GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market by Key Therapy Areas
The key therapy areas in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market are central nervous system and dermatology.
GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market, by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanism of Actions in the GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market
The key mechanism of action in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market is Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABAAgonist.
Key Routes of Administration in the GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market
The key route of administration in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market is oral.
Key Molecule Types in the GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market
The key molecule type in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market is small molecule.
Key Companies in the GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market
The key companies in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market are Baergic Bio Inc, Cerevel Therapeutics Holdings Inc, Engrail Therapeutics Inc, and Saniona AB.
GABA(A) Receptor Subunit Alpha 2 Pipeline Drugs Market, by Companies
To know more about the companies, download a free report sample
Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 Pipeline Drugs Market Report Overview
Key Therapy Areas | Central Nervous System and Dermatology |
Key Mechanism of Actions | Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABAAgonist |
Key Routes of Administration | Oral |
Key Molecule Types | Small Molecule |
Key Companies | Baergic Bio Inc, Cerevel Therapeutics Holdings Inc, Engrail Therapeutics Inc, and Saniona AB |
Scope
This report provides:
- A snapshot of the global therapeutic landscape for Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2).
- Reviews of targeted therapeutics for Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) therapeutics and enlists all their major and minor projects.
- Assessment of Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type.
- Summarization of all the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) targeted therapeutics.
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2).
- Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding the Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Cerevel Therapeutics Holdings Inc
Engrail Therapeutics Inc
Saniona AB
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas of the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market?
The key therapy areas of the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market are central nervous system and dermatology.
-
What are the key mechanism of actions in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market?
The mechanism of action in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market is Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABAAgonist.
-
What are the key routes of administration in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market?
The route of administration in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market is oral.
-
What are the key molecule types in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market?
The key molecule type in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market is small molecule.
-
Which are the key companies in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market?
The key companies in the GABA(A) Receptor Subunit Alpha 2 pipeline drugs market are Baergic Bio Inc, Cerevel Therapeutics Holdings Inc, Engrail Therapeutics Inc, and Saniona AB.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.